Identification and functional characterization of the heterozygous LMNA c.1488 + 2T>C splice variant in a Chinese patient with familial partial lipodystrophy type 2

Background Familial partial lipodystrophy type 2 (FPLD2) is an autosomal dominant genetic disorder caused by mutations in the LMNA gene, characterized by the selective loss of adipose tissue, and is associated with various metabolic abnormalities. In this study, we investigated a Chinese woman diagnosed with FPLD2 to elucidate the effects of a novel intronic variant in the LMNA gene on pre-mRNA splicing. The LMNA variant c.1488 + 2T>C has been previously reported by Shchagina et al., in 2025. Here, we describe a Chinese woman with a severe FPLD2 phenotype carrying this heterozygous splice-site variant and provide functional characterization of its effects on pre-mRNA splicing. Methods Whole-exome sequencing (WES) was used to identify the causative variant within the family, and the identified variant was subsequently validated through Sanger sequencing. We adopted bioinformatic tools to predict the potential effect of the identified mutation on splicing. An in vitro minigene splicing assay was also performed to evaluate the effect of this novel mutation on RNA splicing, with the splicing outcomes confirmed by Sanger sequencing. Results A heterozygous mutation, c.1488 + 2T>C (exon 8, NM_170707), in the LMNA gene was identified in a Chinese female patient via whole-exome and Sanger sequencing. This mutation was absent in the patient’s parents. In accordance with American College of Genetic Medicine and Genomics guidelines, the variant was initially classified as uncertain significance (VUS) by applying criteria PVS1_Moderate, PM6, and PM2_Supporting. Bioinformatic analyses using BDGP, NetGene2-2.42, and RDDC indicated that the variant would likely affect splicing. Our in vitro minigene assay further confirmed that the c.1488 + 2T>C mutation in LMNA resulted in three distinct aberrant mRNA isoforms: retention of 59 bp from intron 8 (NM_170707.4: c.1488 + 1_1488 + 59ins), deletion of nine nucleotides from exon 8 (gtggtgacg; NM_170707.4: c.1480_1488del), and exon 8 skipping (NM_170707.4: c.1381_1488del). These splicing events generated three distinct protein variants: a truncated protein with a premature stop codon (p.Ile497AlafsTer70), a protein lacking three amino acids (p.Val494_Thr496del), and a protein with a partial amino acid sequence deletion (p.Asp461_Thr496del). Conclusion We herein identified a novel heterozygous mutation, c.1488 + 2T>C, in the LMNA gene that induced abnormal mRNA splicing. This study expands the spectrum of LMNA gene variants, enhances the clinical understanding of LMNA-related disorders, facilitates precise genetic counseling for the affected family, and offers guidance for early diagnosis and disease management. Furthermore, it validates the minigene assay as a robust method for characterizing mRNA splicing profiles.

Authors

Institutions

Publication Details

Journal
Frontiers in Genetics
Published
2026-11-19
DOI
https://doi.org/10.3389/fgene.2026.1963869
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Identification and functional characterization of the heterozygous LMNA c.1488 + 2T>C splice variant in a Chinese patient with familial partial lipodystrophy type 2

Fei Yan, Jingru Qu, Mengmeng Yang, Weili Wang et al.
3 links
Frontiers in Genetics
Genomics and Rare Diseases
article

Identification and functional characterization of the heterozygous LMNA c.1488 + 2T>C splice variant in a Chinese patient with familial partial lipodystrophy type 2

Fei Yan, Jingru Qu, Mengmeng Yang, Weili Wang, Fuqiang Liu, Mengrui Chai, Hualin Liu, Rongrong Zhang, Yinuo Zhai, Fei Liu, Huizhen Zheng, Linjia Guo
article en

Abstract

Background Familial partial lipodystrophy type 2 (FPLD2) is an autosomal dominant genetic disorder caused by mutations in the LMNA gene, characterized by the selective loss of adipose tissue, and is associated with various metabolic abnormalities. In this study, we investigated a Chinese woman diagnosed with FPLD2 to elucidate the effects of a novel intronic variant in the LMNA gene on pre-mRNA splicing. The LMNA variant c.1488 + 2T>C has been previously reported by Shchagina et al., in 2025. Here, we describe a Chinese woman with a severe FPLD2 phenotype carrying this heterozygous splice-site variant and provide functional characterization of its effects on pre-mRNA splicing. Methods Whole-exome sequencing (WES) was used to identify the causative variant within the family, and the identified variant was subsequently validated through Sanger sequencing. We adopted bioinformatic tools to predict the potential effect of the identified mutation on splicing. An in vitro minigene splicing assay was also performed to evaluate the effect of this novel mutation on RNA splicing, with the splicing outcomes confirmed by Sanger sequencing. Results A heterozygous mutation, c.1488 + 2T>C (exon 8, NM_170707), in the LMNA gene was identified in a Chinese female patient via whole-exome and Sanger sequencing. This mutation was absent in the patient’s parents. In accordance with American College of Genetic Medicine and Genomics guidelines, the variant was initially classified as uncertain significance (VUS) by applying criteria PVS1_Moderate, PM6, and PM2_Supporting. Bioinformatic analyses using BDGP, NetGene2-2.42, and RDDC indicated that the variant would likely affect splicing. Our in vitro minigene assay further confirmed that the c.1488 + 2T>C mutation in LMNA resulted in three distinct aberrant mRNA isoforms: retention of 59 bp from intron 8 (NM_170707.4: c.1488 + 1_1488 + 59ins), deletion of nine nucleotides from exon 8 (gtggtgacg; NM_170707.4: c.1480_1488del), and exon 8 skipping (NM_170707.4: c.1381_1488del). These splicing events generated three distinct protein variants: a truncated protein with a premature stop codon (p.Ile497AlafsTer70), a protein lacking three amino acids (p.Val494_Thr496del), and a protein with a partial amino acid sequence deletion (p.Asp461_Thr496del). Conclusion We herein identified a novel heterozygous mutation, c.1488 + 2T>C, in the LMNA gene that induced abnormal mRNA splicing. This study expands the spectrum of LMNA gene variants, enhances the clinical understanding of LMNA-related disorders, facilitates precise genetic counseling for the affected family, and offers guidance for early diagnosis and disease management. Furthermore, it validates the minigene assay as a robust method for characterizing mRNA splicing profiles.

Frontiers in GeneticsVol. 17
Shandong University (CN), Fourth People’s Hospital of Jinan (CN), Jinan Central Hospital (CN), Jinan Infectious Disease Hospital (CN), Qilu Hospital of Shandong University (CN)
Natural Science Foundation of Shandong Province, National Key Research and Development Program of China
Good health and well-being
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon